Skip to content

Ayurvedic management of rajyakshma(oulmonary tuberclosis)

â??ROLE OF ELADI GUTIKA AND VYAGHRIADI KASHAYA AS AN ADD ON THERAPY IN THE MANAGEMENT OF RAJYAKSHMA (PULMONARY TUBERCLOSIS) A RANDOMISED STANDARD AKT CONTROLLED COMPARATIVE CLINICAL STUDYâ??â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035867
Enrollment
30
Registered
2021-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40-J47- Chronic lower respiratory diseases

Interventions

None listed

Sponsors

PANDITH TARANATH GOVERNMENT AYURVEDIC MEDICAL COLLEGE AND HOSPITAL BELLARI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA 1)Subjects diagnosed with pulmonary tuberclosis 2)Male and female aged between 20-60 yrs 3)Patient under the treatment of AKT that patient will be taken for standard group 4)Patients who are having the symptoms of rajyakshma like kasa,swasa,jwara 5)COPD cases suspected to be rajayakshma.

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1)Patients having extra pulmonary tuberclosis 2)Pulmonary tuberculosis along with the other diseases like AIDS,HIV,DM 3) Pregnant and lactating mother 4)Patient having multi drug resistant

Design outcomes

Primary

MeasureTime frame
Efficacy of rasayana to improve the immunity and to counteract the adverse drug reaction caused by anti tubercular drug in pulmonary tuberculosIS.Timepoint: Efficacy of rasayana to improve the immunity and to counteract the adverse drug reaction caused by anti tubercular drug in pulmonary tuberculosIS.

Secondary

MeasureTime frame
Efficacy of rasayana to improve the immunity and to counteract the adverse drug reaction caused by anti tubercular drug in pulmonary tuberculosIS.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr puja yadav

TGAMC BALLARY

drfareedabegumshaikh@gmail.com9980190268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026